For the proof-of-concept experiment with a TEDbody, we chose to deliver the HLA-A*02:01-restricted CTL epitope of CMV pp65-derived CMVp495–503 into the cytosol of target tumor cells. This evidence concerns the gene HLA-A and neoplasm.